Zhejiang Starry Pharmaceutical Co.,Ltd. (603520.SS)
CNY 9.37
(-0.85%)
CNY 9.37
(-0.85%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 464.77 Million CNY | -9.3% |
| 2022 | 512.45 Million CNY | -31.49% |
| 2021 | 747.97 Million CNY | 24.38% |
| 2020 | 601.35 Million CNY | 7.54% |
| 2019 | 559.18 Million CNY | 55.15% |
| 2018 | 360.4 Million CNY | 35.16% |
| 2017 | 266.64 Million CNY | 3.87% |
| 2016 | 256.7 Million CNY | -0.69% |
| 2015 | 258.48 Million CNY | 24.59% |
| 2014 | 207.46 Million CNY | 13.75% |
| 2013 | 182.38 Million CNY | 28.37% |
| 2012 | 142.08 Million CNY | -11.96% |
| 2011 | 161.37 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 124.93 Million CNY | -9.49% |
| 2024 Q3 | 96.51 Million CNY | -19.22% |
| 2024 Q1 | 138.03 Million CNY | 14.56% |
| 2023 Q3 | 141.19 Million CNY | 1.37% |
| 2023 Q4 | 120.49 Million CNY | -14.66% |
| 2023 FY | 464.77 Million CNY | -9.3% |
| 2023 Q1 | 116.1 Million CNY | -25.4% |
| 2023 Q2 | 139.28 Million CNY | 19.96% |
| 2022 Q4 | 155.63 Million CNY | 92.27% |
| 2022 Q3 | 80.94 Million CNY | -29.01% |
| 2022 Q2 | 114.02 Million CNY | -29.55% |
| 2022 Q1 | 161.85 Million CNY | -27.02% |
| 2022 FY | 512.45 Million CNY | -31.49% |
| 2021 Q3 | 160.6 Million CNY | -21.46% |
| 2021 FY | 747.97 Million CNY | 24.38% |
| 2021 Q1 | 161.11 Million CNY | 40.25% |
| 2021 Q2 | 204.47 Million CNY | 26.92% |
| 2021 Q4 | 221.78 Million CNY | 38.1% |
| 2020 Q1 | 131.94 Million CNY | -9.05% |
| 2020 Q3 | 144.15 Million CNY | -31.48% |
| 2020 FY | 601.35 Million CNY | 7.54% |
| 2020 Q2 | 210.38 Million CNY | 59.45% |
| 2020 Q4 | 114.87 Million CNY | -20.31% |
| 2019 Q2 | 149.08 Million CNY | 29.04% |
| 2019 FY | 559.18 Million CNY | 55.15% |
| 2019 Q4 | 145.07 Million CNY | -2.95% |
| 2019 Q3 | 149.48 Million CNY | 0.27% |
| 2019 Q1 | 115.53 Million CNY | 18.4% |
| 2018 Q2 | 95.8 Million CNY | 25.94% |
| 2018 Q1 | 76.07 Million CNY | 52.29% |
| 2018 FY | 360.4 Million CNY | 35.16% |
| 2018 Q4 | 97.57 Million CNY | 7.3% |
| 2018 Q3 | 90.94 Million CNY | -5.08% |
| 2017 FY | 266.64 Million CNY | 3.87% |
| 2017 Q2 | 75.35 Million CNY | 0.19% |
| 2017 Q3 | 66.12 Million CNY | -12.26% |
| 2017 Q4 | 49.95 Million CNY | -24.45% |
| 2017 Q1 | 75.21 Million CNY | 20.33% |
| 2016 Q3 | 58.98 Million CNY | -13.93% |
| 2016 Q2 | 68.53 Million CNY | 2.8% |
| 2016 Q4 | 62.5 Million CNY | 5.96% |
| 2016 FY | 256.7 Million CNY | -0.69% |
| 2016 Q1 | 66.67 Million CNY | -14.52% |
| 2015 Q1 | 75.41 Million CNY | 101.55% |
| 2015 FY | 258.48 Million CNY | 24.59% |
| 2015 Q4 | 77.99 Million CNY | 63.92% |
| 2015 Q3 | 47.58 Million CNY | -17.25% |
| 2015 Q2 | 57.49 Million CNY | -23.76% |
| 2014 Q4 | 37.41 Million CNY | 0.0% |
| 2014 FY | 207.46 Million CNY | 13.75% |
| 2013 FY | 182.38 Million CNY | 28.37% |
| 2012 FY | 142.08 Million CNY | -11.96% |
| 2011 FY | 161.37 Million CNY | 0.0% |